Pamela L Schwartzberg

Title: The Innovative Contributions of Pamela L Schwartzberg

Introduction

Pamela L Schwartzberg is a notable inventor based in Bethesda, MD (US). She has made significant contributions to the field of biomedical research, particularly in the modulation of angiogenesis. Her work has implications for various medical conditions, including cancer and cardiovascular diseases.

Latest Patents

Pamela holds 1 patent titled "Methods and compositions useful for modulation of angiogenesis using tyrosine kinase Src." This invention describes methods for modulating angiogenesis in tissues using Src protein, modified Src protein, and nucleic acids encoding for such. Specifically, the invention outlines methods for inhibiting angiogenesis using an inactive Src protein or nucleic acids encoding therefor, as well as for potentiating angiogenesis using an active Src protein or nucleic acids encoding therefor. Additionally, the invention discusses the use of gene delivery systems for providing nucleic acids encoding for the Src protein or its modified forms.

Career Highlights

Throughout her career, Pamela has worked with prestigious institutions such as The Scripps Research Institute and the National Institutes of Health, a component of the US Department of Health & Human Services. Her research has been pivotal in advancing our understanding of angiogenesis and its modulation.

Collaborations

Pamela has collaborated with esteemed colleagues, including David A Cheresh and Brian Eliceiri, contributing to a rich exchange of ideas and advancements in her field.

Conclusion

Pamela L Schwartzberg's innovative work in the modulation of angiogenesis showcases her dedication to advancing biomedical research. Her contributions continue to influence the scientific community and hold promise for future medical applications.